issued
on 20 Dec 2022
Last Applicant/ Owned by
10275 W. Higgins Road,
Rosemont
IL
60018
Serial Number
90701405 filed on 10th May 2021
Registration Number
N/A
Correspondent Address
Jessica R. Manganello
Filing Basis
1. intent to use current
Disclaimer
"BIOPHARMA"
"BIOPHARMA" The mark consists of The words "Reistone" and "Biopharma" in a custom designed font, separated by a bold line, with "Reistone" positioned above the bold line and "Biopharma" positioned below the bold line. Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related disRead More
Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of auto immune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of auto immune, immune system, dermatological, and gastroenterological related diseases and disorders; Therapeutic pharmaceutical for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders
No 90701405
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
The mark consists of The words "Reistone" and "Biopharma" in a custom designed font, separated by a bold line, with "Reistone" positioned above the bold line and "Biopharma" positioned below the bold line.
| Status Date | Action Taken |
|---|---|
| 20th Dec 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 25th Oct 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 25th Oct 2022 | PUBLISHED FOR OPPOSITION |
| 05th Oct 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 19th Sep 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 10th Aug 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 10th Aug 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Aug 2022 | ASSIGNED TO LIE |
| 18th Jul 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 18th Jul 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
